Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00125229 · ClinicalTrials.gov registry record
Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients
A clinical trial, sponsored by The University of Texas Health Science Center at San Antonio.
- Terminated
- Registry status
- 10
- Enrollment target
NCT00125229: Clinical Trial study, sponsored by The University of Texas Health Science Center at San Antonio.
NCT00125229 is a clinical trial that was terminated before completion, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00125229 was terminated before completion, sponsored by The University of Texas Health Science Center at San Antonio.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This is a clinical study comparing the physiologic effects of two hypertonic solutions (mannitol, hypertonic saline) with a particular emphasis on changes in cerebral blood flow in patients with intracranial hypertension following serious traumatic brain injury (TBI).
Interventions
- DRUG Mannitol
- DRUG Hypertonic Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-08 |
| Est. Completion | 2006-06 |
Why NCT00125229 stopped before completion
NCT00125229 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Mannitol is the first listed.
NCT00125229 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00125229 about?
NCT00125229 is a clinical study titled "Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients". This is a clinical study comparing the physiologic effects of two hypertonic solutions (mannitol, hypertonic saline) with a particular emphasis on changes in cerebral blood flow in patients with intracranial hypertension following serious traumatic brain injury (TBI).
What is the current status of trial NCT00125229?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2005-08. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00125229?
The interventions under investigation include: Mannitol (DRUG), Hypertonic Saline (DRUG).
Who is sponsoring clinical trial NCT00125229?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia